Immunologic phenotype of patients with long-COVID syndrome of 1-year duration

Immunologic phenotype of patients with long-COVID syndrome of 1-year duration

BackgroundThe pathophysiology of long-COVID remains unknown, and information is particularly limited for symptoms of very long duration. We aimed to assess the serological, T-cell immune responses and ANA titers of patients with long-COVID-19 syndrome of 1-year duration.MethodsProspective, longitudi...

Full description

Bibliographic Details
Main Authors: Javier García-Abellán, Marta Fernández, Sergio Padilla, José Alberto García, Vanesa Agulló, Valle Lozano, Nuria Ena, Lidia García-Sánchez, Félix Gutiérrez, Mar Masiá
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Immunology
Subjects:
COVID-19
long COVID
post-COVID-19 syndrome
antibody response, antinuclear antibodies (ANA)
one year
T-cell immune response
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.920627/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.920627/full

Similar Items